Alyglo
Scope
Date
~
-
Bio & PharmaGC Biopharma acquires ABO Holding for $96 mn
South Korea’s GC Biopharma Corp. said on Thursday it acquired the US-based medical-grade source blood plasma company ABO Holding Inc. The...
Dec 12, 2024 (Gmt+09:00)
-
Bio & PharmaGC Biopharma exports Alyglo to US
South Korea’s major pharmaceutical company GC Biopharma Corp. announced on Monday that it shipped the initial volume of Alygro, its immunoglob...
Jul 09, 2024 (Gmt+09:00)
-
Bio & PharmaGC Biopharma aims to boost Alyglo sales sixfold in the US
CHEONGJU, North Chungcheong Province -- South Korea’s major pharmaceutical company GC Biopharma Corp. aims to raise the sales of Alyglo, its i...
Feb 28, 2024 (Gmt+09:00)
-
Bio & PharmaGC Biopharma gets FDA approval for Alyglo
South Korea’s GC Biopharma Corp. announced on Monday that it received approval from the US Food and Drug Administration (FDA) for the immuno...
Dec 18, 2023 (Gmt+09:00)
Latest News
- 1 BYD’s Atto 3 overtakes Tesla’s Model Y as best-selling EV in South Korea
- 2 Korea’s top cinema chains seek merger to counter box office slump
- 3 S.Korea’s GEPS to commit $143 million to foreign mid-cap buyout funds
- 4 CJ CheilJedang to open $72 mn dumpling plant in Japan
- 5 LG Electronics breaks ground on $600 million home appliance plant in India
